Novocure
NVCR
#4738
Rank
โ‚น201.78 B
Marketcap
Country
โ‚น1,742
Share price
0.58%
Change (1 day)
19.24%
Change (1 year)
Categories

Revenue for Novocure (NVCR)

Revenue in 2026 (TTM): โ‚น60.38 Billion

According to Novocure 's latest financial reports the company's current revenue (TTM ) is โ‚น64.72 Billion. In 2025 the company made a revenue of โ‚น58.83 Billion an increase over the revenue in the year 2024 that were of โ‚น51.91 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novocure from 2015 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น60.38 B2.65%
2025 โ‚น58.83 B13.31%
2024 โ‚น51.91 B22.45%
2023 โ‚น42.40 B-4.73%
2022 โ‚น44.50 B11.76%
2021 โ‚น39.82 B10.15%
2020 โ‚น36.15 B44.31%
2019 โ‚น25.05 B44.43%
2018 โ‚น17.34 B53.46%
2017 โ‚น11.30 B100.67%
2016 โ‚น5.63 B156.17%
2015 โ‚น2.19 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Organovo
ONVO
โ‚น13.81 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
โ‚น2.09 B-96.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
โ‚น103.94 B 60.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
โ‚น64.72 B 0.00% Jersey